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Summary
Nephronophthisis, an autosomal-recessive cystic kidney
disease, is the most frequent monogenic cause for renal
failure in childhood. Infantile and juvenile forms of ne-
phronophthisis are known to originate from separate
gene loci. We describe here a new disease form, adoles-
cent nephronophthisis, that is clearly distinct by clinical
and genetic findings. In a large, 340-member consan-
guineous Venezuelan kindred, clinical symptoms and re-
nal pathology were evaluated. Onset of terminal renal
failure was compared with that in a historical sample of
juvenile nephronophthisis. Onset of terminal renal fail-
ure in adolescent nephronophthisis occurred signifi-
cantly later (median age 19 years, quartile borders 16.0
and 25.0 years) than in juvenile nephronophthisis (me-
dian age 13.1 years, quartile borders 11.3 and 17.3
years; Wilcoxon test ). A total-genome scan ofP = .0069
linkage analysis was conducted and evaluated by LOD
score and total-genome haplotype analyses. A gene locus
for adolescent nephronophthisis was localized to a re-
gion of homozygosity by descent, on chromosome 3q22,
within a critical genetic interval of 2.4 cMbetween flank-
ing markers D3S1292 and D3S1238. The maximum
LOD score for D3S1273 was 5.90 (maximum recom-
bination fraction .035). This locus is different than that
identified for juvenile nephronophthisis. These findings
will have implications for diagnosis and genetic coun-
seling in hereditary chronic renal failure and provide the
basis for identification of the responsible gene.
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Introduction
Nephronophthisis, a hereditary cystic kidney disease, is
the most frequent monogenic cause of chronic renal fail-
ure in children (Kleinknecht 1989; Fivush et al. 1998).
Fanconi et al. introduced the term “familial juvenile
nephronophthisis” (NPH1 [MIM 256100]) to describe
a disease characterized by autosomal-recessive inheri-
tance, a defect in urinary concentrating capacity, severe
anemia, and progressive renal failure that leads to death
before puberty (Smith and Graham 1945; Fanconi et al.
1951). Renal histology is characterized by disintegrated
tubular basement membranes, tubular atrophy and cyst
formation, and a sclerosing tubulointerstitial nephro-
pathy (Zollinger et al. 1980; Waldherr et al. 1982). Cor-
ticomedullary cysts occur late in the disease process
(Blowey et al. 1996). In NPH1, the responsible gene
(NPHP1), which is localized on chromosome 2q12-q13
(Antignac et al. 1993; Hildebrandt et al. 1993b), has
recently been identified by positional cloning (Hilde-
brandt et al. 1997a; Saunier et al. 1997). Its gene prod-
uct, nephrocystin, is novel and encodes an src homology
3 (SH3) domain. In ∼85% of patients with NPH1, large
homozygous deletions of this gene are found (Konrad
et al. 1996). In contrast, infantile nephronophthisis
(NPH2 [MIM 602088]) leads to terminal renal failure
within the first 3 years of life (Bodaghi et al. 1987; Gag-
nadoux et al. 1989; Haider et al. 1998). Morphologi-
cally, this type of hereditary tubulointerstitial nephro-
pathy differs from NPH1 by the presence of cortical
microcysts and by the absence of medullary cysts and
typical tubular–basement membrane changes. A gene lo-
cus for NPH2 has been localized to 9q22-q31 (Haider
et al. 1998).
Only in the recessive form of the disease have occa-
sionally extrarenal associations—such as tapetoretinal
degeneration, cerebellar ataxia, skeletal involvement,
and liver disease—been described (Loken et al. 1961;
Senior et al. 1961; Mainzer et al. 1970; Boichis et al.
1973; Antignac et al. 1998; Hildebrandt 1999). A gene
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locus for nephronophthisis associated with extrarenal
disease manifestation has not yet been found.
The term “autosomal-dominant medullary cystic dis-
ease” (ADMCKD) has been used for a disease indistin-
guishable, by pathological means, from recessive ne-
phronophthisis (Goldman et al. 1966; Strauss and
Sommers 1967). Two loci for the autosomal-dominant
disease, ADMCKD1 (MIM 174000) on chromosome
1q21 (Christodoulou et al. 1998) and ADMCKD2
(MIM 603860) on chromosome 16p12 (Scolari et al.
1999), have been described. Besides the different inher-
itance pattern, the main feature distinguishing between
recessive and dominant disease conditions has been a
different age at onset of terminal renal failure. Because
of the morphological similarities of the above-described
diseases, the term “nephronophthisis/medullary cystic
disease complex” has been used to summarize this group
of diseases (Gardner 1971).
We here describe a large Venezuelan kindred with a
hereditary kidney disease of the nephronophthisis/med-
ullary cystic disease complex. Inheritance appeared to
be autosomal recessive, and renal failure was reached,
in many cases, at age 125 years. This newly identified
disease form was termed “adolescent nephronophth-
isis,” since it is clearly distinct from NPH1, by age at
onset and by a separate gene locus.
Subjects and Methods
Pedigree and Clinical Evaluation
In a large, 340-member Venezuelan pedigree (fig. 1),
blood samples were obtained, after informed consent
was given, from 112 family members, including 6 af-
fected individuals. Medical records were reviewed for all
patients from the kindred who had received treatment
!12 years previously at the Hospital of the Universidad
de Los Andes, Merida, Venezuela. Specifically, family
history, presenting symptoms, serum creatinine mea-
surements at the first medical visit, results from renal
ultrasound, and age at start of first renal replacement
therapy were noted.
Statistical Analysis of Age at Renal Failure
For life-table analysis, “renal death” was defined as
start of renal replacement therapy, occurrence of a serum
creatinine 15.5 mg/dl, or death caused by uremia. The
cumulative probability of terminal renal failure was de-
termined for adolescent nephronophthisis and was com-
pared with that in a historical sample of genetically
proved NPH1 (Hildebrandt et al. 1997b), by use of the
life-table method (“survival analysis”) of Kaplan and
Meier (1958). The data were compared by use of the
Wilcoxon test (Gretz 1994).
Histopathology
Renal biopsy specimens from eight affected individ-
uals, including one nephrectomy specimen (index case),
which had been obtained previously for diagnostic pur-
poses, were reevaluated by use of standard histopa-
thology staining procedures.
Total-Genome Scan
Genomic DNA was isolated by standard methods, di-
rectly from blood samples (Sambrook et al. 1989) or
from peripheral blood lymphocytes after Epstein-Barr
virus transformation (Steel et al. 1977). Total-genome
linkage analysis was performed by use of 297 micro-
satellite markers from the MDC-microsatellite set, with
an average spacing of 11 cM and, for further fine map-
ping, with 20 additional microsatellites from the region
of 3q22 (Dib et al. 1996; Broman et al. 1998). Micro-
satellite markers were amplified individually by use of
an MJ Research Multicycler PTC225 Tetrad (Biozym).
After pooling, markers were separated on an ABI377XL
DNA sequencer and were evaluated by use of GENE-
SCAN software, as described elsewhere (Saar et al.
1997).
The total-genome scan was performed in a subset of
the kindred (fig. 1), containing 6 affected (individuals
A137, A134, D4, D2, D1, and D12) and 18 unaffected
individuals (individuals A130, A121, A138, A132,
A133, A135, A136, D103, D104, D43, D3, D8, D30,
D9, D5, D7, D31, and D33). The results were evaluated
by analyses of two-point LOD scores between the disease
locus and microsatellite markers, by use of the MLINK
subroutine of the computer program package FAST-
LINK (Lathrop et al. 1984; Schaffer 1996) and with help
of the program LODVIEW (Hildebrandt et al. 1993a).
The ILINK component of the FASTLINK package was
used to calculate maximum LOD scores (Zmax) at various
recombination fractions (v). A high number of inbreed-
ing loops increased the computational time enormously.
Therefore, LOD-score analysis was performed after frag-
mentation of the large pedigree into four subsets (A–D)
with preservation of most of the inbreeding loops (fig.
1). To test for the potential influence of fragmentation
of the pedigree, we performed linkage analyses in various
subsets of the pedigree, thus demonstrating the robust-
ness of the strategy used. For linkage analysis, minimal
diagnostic criteria for affected status were defined on the
basis of a priori clinical criteria. An individual was re-
garded as affected by adolescent nephronophthisis only
if the following diagnostic criteria were fulfilled: (1) ter-
minal renal failure was present, (2) the individual be-
longed to the kindred, (3) results of urine analysis were
normal, and (4) urinary-tract obstruction was not seen
on sonography. The diagnosis was supported by the
availability of eight biopsy specimens compatible with
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Figure 2 Cumulative probability of terminal renal failure. The
cumulative probability of terminal renal failure was determined for
24 patients from the large kindred with adolescent nephronophthisis
(solid lines) and was compared with that in a historical sample of
genetically proved NPH1 (dashed lines [Hildebrandt et al. 1997b]),
by use of the life-table method of Kaplan and Meier (1958). The data
were compared by use of the Wilcoxon test. In the group with ado-
lescent nephronophthisis, one patient, and, in the group with NPH1,
four patients, were censored (vertical strokes), because terminal renal
failure did not occur during the observation period.
Figure 1 Haplotypes and recombination in the Venezuelan kindred with adolescent nephronophthisis. Genotypes are shown in centromere-
to-telomere order (top to bottom) for microsatellite markers D3S1292, D3S1587, D3S1273, D3S1290, D3S3713, D3S3657, D3S1238, and
D3S3684 on chromosome 3q22. Inferred alleles are shown in parentheses. For genotypes represented by a question mark (?), no data were
available. Haplotypes were assembled by minimization of recombinants, and the chromosomal region cosegregating with the disease locus is
represented by a blackened bar. No attempt has been made to show crossovers on the nondisease chromosome, depicted by an unblackened
bar. Vertical positioning of pedigree members does not represent generational order, because of extended consanguinity within the pedigree.
Consanguineous relationships are depicted by a double line. Individuals whose numerical designations are below their symbols were available
for genotyping. In the index case (left, above arrow) a nephrectomy specimen, and in seven individuals a renal biopsy (left arrow), were available.
For LOD-score analysis, the pedigree was fragmented into four subsets (A–D). Characters below symbols identify the individuals who were
used for linkage calculation in each subset. Circles denote females, squares males, blackened symbols affected individuals, unblackened symbols
unaffected individuals, and symbols with a slash deceased family members. Note that D3S1587, D3S1273, D3S1290, D3S3713, and D3S3657
are cosegregating markers, which are compatible with linkage in five affected individuals, as well as in all facultative and obligate carriers.
nephronophthisis in members from the same pedigree.
An individual was considered to be likely not affected
by adolescent nephronophthisis if the serum creatinine
measurement was normal. Because affected status is age
dependent, for these individuals an age-dependent risk
was assigned. In accordance with data on age-related
penetrance in this pedigree (fig. 2), liability classes were
assigned as follows: affected subjects with adolescent
nephronophthisis were assigned liability class 1 with
penetrance vectors {.0000; .0000; 1.0000}; unaffected
individuals age 147 years were assigned liability class 2
{.0000; .0000; .9900}, age 26–46 years liability class 3
{.0000; .0000; .9000}, age 20–25 years liability class 4
{.0000; .0000; .7000}, age 16–19 years liability class 5
{.0000; .0000; .5000}, age 13–15 years liability class 6
{.0000; .0000; .3000}, and age 11–13 years liability class
7 {.0000; .0000; .1000}. Unaffected individuals age !11
years were not included in the linkage analysis because
their disease status was unknown. The gene frequency
of adolescent nephronophthisis was set at .001. Allele
frequencies of microsatellite markers were arbitrarily as-
signed a value of 1/n, where n refers to the number of
alleles observed. Because the use of incorrect values for
linkage analysis can cause false-positive results, LOD
scores were calculated in a second model, using only
data on affected individuals and thus testing for ro-
bustness of linkage. Linkage analysis and total-genome
haplotype analysis were performed with the program
GENEHUNTER (Kruglyak et al. 1996). For graphic rep-
resentation of pedigree and haplotype data, the program
CYRILLIC, version 2.0, was used (Cherwell Scientific).
Results
Pedigree and Clinical Characteristics
The large 340-member kindred with a hereditary kid-
ney disease originates from a remote area in the Vene-
zuelan Andes. A 247-member subset of this pedigree is
shown infigure 1. Fifty-five affected individuals were de-
scendants of known consanguineous relationships, with
20 consanguinity loops identified altogether. Sex distri-
bution among affected individuals showed a prepon-
derance of females, with a ratio of 2.2 : 1 (20 females
and 9 males). The percentage of affected siblings was
29.4% when only families with at least one affected child
and more than two children were considered. This find-
ing, together with the lack of direct disease transmission
and the high degree of consanguinity, strongly suggests
an autosomal-recessive mode of inheritance.
Twenty-three of 24 patients presented with signs of
terminal renal failure and showed a constellation of
symptoms typical of nephronophthisis: most of the pa-
tients suffered from anemia when they first came to med-
ical attention. Eight of 24 patients had a history typical
of nephronophthisis, with symptoms of polydipsia, poly-
uria, and secondary enuresis. Urine microscopy revealed
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no leukocyturia or hematuria at admission. No protein-
uria was detected. Renal ultrasound showed no urinary-
tract anomalies. Fundoscopic examination did not reveal
signs of retinitis pigmentosa. No other associated ex-
trarenal disease manifestation, including gout, was
noted.
Life-table analysis for onset of terminal renal failure
yielded a median age at “renal death” of 19.0 years
(quartiles are 25%, 16.0 years; and 75%, 25.0 years),
whereby “renal death” was defined as the start of renal
replacement therapy, serum creatinine 15.5 mg/dl, or
death due to uremia. The resulting survival curve showed
no major plateau formation, indicating homogeneity
within the group of patients with adolescent nephron-
ophthisis (fig. 2). Comparison of life-table data from this
pedigree versus those for a historical sample of molec-
ular-genetically proved NPH1 revealed a significant dif-
ference, in the age at onset of terminal renal failure, for
both diseases (Wilcoxon test, ). For compari-P = .0069
son, life-table analysis for NPH1 yielded, for onset of
terminal renal failure, a median age of 13.1 years (quar-
tiles are 25%, 11.3 years; and 75%, 17.3 years [Hil-
debrandt et al. 1997b]). Thus, median age at onset of
terminal renal failure occurred 5.9 years later in this
kindred than in patients with NPH1. To distinguish be-
tween the two diseases, we use the term “adolescent
nephronophthisis” for the disease variant observed in
this kindred.
Pathology
Affected individuals of the kindred exhibited typical
macroscopic and microscopic features of nephronoph-
thisis. In the index case, a nephrectomy specimen was
examined (fig. 3, top). The small end-stage kidney has
a pitted, granular surface. The cortex is thin and fibrotic.
The cut surface shows multiple rounded cysts localized
mainly at the corticomedullary border of the kidney.
Previous histological examination of renal biopsies by a
local pathologist had described a severe sclerosing tubu-
lointerstitial nephropathy in all cases. Renal histology
for three individuals was reviewed. All specimens
showed alterations typical of nephronophthisis (fig. 3,
bottom). Tubular basement membranes are altered, with
segments of thickening, thinning, and folding and a mul-
tilayered appearance. Tubules are atrophic and are lined
by a flattened dedifferentiated epithelium. Distal tubules
seem to be predominantly affected, whereas proximal
tubules are well preserved in many areas. Tubules are
surrounded by mild to moderate mononuclear infiltrates
and by diffuse interstitial fibrosis with an increase in
collagen fibers (fig. 3, bottom). Many glomeruli are com-
pletely obsolescent. Nonsclerosed glomeruli frequently
disclose both retraction of their tufts and concentric peri-
glomerular fibrosis with thickening of Bowman’s cap-
sule. Glomerular mesangial cellularity is within the nor-
mal range, and basement membranes of nonsclerotic
glomeruli appear normal. In all specimens, prominent
vascular changes are present and consist of thickening
of arteriolar and arterial walls, which is due to medial
hypertrophy. Concentric intimal fibrosis with narrowing
of the arterial lumina is prominent in two biopsies and
in the nephrectomy sections. We conclude that histolog-
ical findings in adolescent nephronophthisis are gener-
ally not distinguishable from those in NPH1.
Linkage Analysis
Before performing a genomewide search for linkage
in the large Venezuelan kindred, we evaluated potential
candidate genes. Haplotype analysis was performed by
use of markers within and flanking the critical regions
for infantile and NPH1 on chromosomes 9q22-q31 and
2q12-q13, respectively. These loci were excluded from
linkage, indicating that adolescent nephronophthisis is
not allelic with either of the two diseases (data not
shown).
The total-genome scan was performed in a small sub-
set of the kindred, containing 6 affected and 18 unaf-
fected individuals. This screening procedure yielded a
two-point Zmax of 1.60 ( ) at marker D3S1267 onv = .05
the long arm of chromosome 3, as calculated by GENE-
HUNTER. Genotyping data were consistent with a re-
gion of homozygosity by descent in three affected in-
dividuals. By fine mapping of a 15.1-cM region flanked
by markers D3S1267 and D3S3554, a homozygous re-
gion was identified in five of six affected individuals.
When haplotype analyses were evaluated, a proximal
recombination event was detected for marker D3S1292
in individual D1, who is affected by adolescent nephron-
ophthisis, and a distal recombination event was detected
for marker D3S1238 in individual C76, who is an ob-
ligate heterozygous carrier of the disease haplotype (fig.
4). These two flanking markers define a critical interval
of 2.4 cM of sex-averaged genetic distance (Collins et
al. 1996). To illustrate homozygosity by descent, we
showed the PCR products for the marker D3S1238, for
a subset of the examined pedigree (fig. 5). Markers
D3S1587, D3S1273, D3S1290, D3S3713, and D3S3657
are cosegregating markers compatible with linkage in
five affected individuals and in all facultative and obli-
gate carriers of the Venezuelan kindred (fig. 1). Proband
47 homozygously carries the haplotype associated with
affected status. However, at age 10 years, affected status
was uncertain. Only in affected individual D12 was no
cosegregating marker identified, but individual D12 is
partially heterozygous for the disease-associated allele.
When reviewing the clinical findings on individual D12
and other close relatives, we found development of hear-
ing deficit and intermittent hematuria in one of the de-
ceased brothers and in individual D12. Data on the other
affected sibling were not available. Since individual D12
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Figure 3 Macroscopic and microscopic pathology in adolescent nephronophthisis. A, Shrunken kidney with cyst formation predominantly
at the corticomedullary junction in a nephrectomy specimen from the index case. The cortex is thin and fibrotic. B, PAS-stained renal biopsy
specimen from the same individual, with irregularity in thickness of tubular basement membranes, with tubular atrophy and ectasia. In addition,
there are mononuclear interstitial infiltrates and marked interstitial fibrosis. Original magnification #100.
was diagnosed as affected on the basis of a priori criteria,
she was considered to be affected in all LOD-score cal-
culations. Parametric two-point LOD-score analysis
yielded a Zmax of 5.90 ( ) with marker D3S1273,v = .035
giving strongly significant evidence for linkage. When,
as a test for robustness, only haplotype data on affected
individuals were used, the Zmax was 3.57 ( ) withv = .050
marker D3S1273, which is still significant for linkage.
The LOD-score results for markers D3S1292, D3S1587,
D3S1273, D3S1290, D3S3713, D3S3657, and D3S1238
are summarized in table 1.
Discussion
This clinical, pathological, and molecular-genetic
study identifies adolescent nephronophthisis as a novel
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Figure 4 Genetic map of markers of the critical region for ad-
olescent nephronophthisis. The haplotype, depicted as a blackened bar,
cosegregates with the disease. The disease interval is flanked by mark-
ers D3S1292 and D3S1238 and contains a 2.4-cM interval because
of recombination events that occurred in individual D1 and individual
C76, an obligate heterozygote.
Figure 5 Autoradiograph of PCR products of marker D3S1238,
for a subset of individuals of the presented pedigree. Affected indi-
viduals (A137, D1, and A134) are homozygous for the disease-asso-
ciated allele, which they inherited through homozygosity by descent.
One parent (A130) and unaffected siblings are heterozygous for this
allele.
disease entity of the nephronophthisis/medullary cystic
disease complex. Histopathological features and clinical
symptoms are found to be virtually identical to those of
NPH1. However, in adolescent nephronophthisis, me-
dian age at onset of terminal renal failure is significantly
retarded, by 6 years, in comparison with that in NPH1.
Through identification of a distinct gene locus on chro-
mosome 3q22, we clearly defined adolescent nephron-
ophthisis as a separate disease entity.
If adolescent nephronophthisis is considered within
the context of other entities of the nephronophthisis/
medullary cystic disease complex, three groups of dis-
eases must be taken into account. The first group of
diseases comprises recessive, purely renal forms of neph-
ronophthisis. Since clinical symptoms, renal histology,
and mode of inheritance in adolescent nephronophthisis
are virtually indistinguishable from those in NPH1, it is
justifiable to classify this new disease entity as belonging
to this disease group. On the other hand, we were able
to clearly distinguish adolescent nephronophthisis from
NPH2 and NPH1 by exclusion of both gene loci, dem-
onstration of a significantly different age at onset, and
identification of a distinct gene locus for adolescent ne-
phronophthisis. The second group of diseases of the ne-
phronophthisis/medullary cystic disease complex con-
sists of recessive nephronophthisis with extrarenal
associations, such as retinitis pigmentosa (MIM
266900), hepatic fibrosis (Boichis et al. 1973), oculo-
motor apraxia (MIM 257550), or cerebellar ataxia
(MIM 243910). Since extrarenal involvement was not
seen in the large Venezuelan kindred studied, the type
of nephronophthisis observed does not belong to this
group. The third disease group, ADMCKD, shares with
adolescent nephronophthisis identical renal pathology
(Goldman et al. 1966; Strauss and Sommers 1967) and
lack of extrarenal involvement (Gardner 1971). How-
ever, adolescent nephronophthisis can be clearly distin-
guished from this group, since our prior assumption of
recessive inheritance, as judged on the basis of pedigree
structure, was confirmed by demonstration of homo-
zygosity by descent. In addition, the locus identified on
3q22 does not coincide with either the locus for
ADMCKD1, on chromosome 1q21 (Christodoulou et
al. 1998), or the locus for ADMCKD2, on chromosome
16p12 (Scolari et al. 1999). Gout, which is frequently
found in ADMCKD, was absent in individuals with ad-
olescent nephronophthisis. Formerly, the main distin-
guishing feature between autosomal-dominant and -re-
cessive forms was believed to be a difference in onset of
terminal renal failure, because median onset age was 13
years in NPH1 (Antignac et al. 1993; Hildebrandt et al.
1997b) and 31–62 years in ADMCKD, respectively
(Christodoulou et al. 1998; Scolari et al. 1998).
In a review of the literature, only a few familial cases
of nephronophthisis compatible with an autosomal-re-
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Table 1
Two-Point LOD Scores between the Adolescent Nephronophthisis
Locus and Chromosome 3 Markers in the Venezuelean Pedigree
MARKER
LOD SCORE AT v =
Zmax (v).00 .05 .10 .15 .20 .30
D3S1292 3.064 3.529 3.156 2.664 2.142 1.162 3.724 (.032)
D3S1587 1.370 2.170 1.893 1.537 1.188 .608 2.441 (.034)
D3S1273 3.931 5.606 5.034 4.245 3.407 1.848 5.904 (.035)
D3S1290 2.966 4.127 3.772 3.182 2.540 1.374 4.723 (.043)
D3S3713 4.807 5.617 5.041 4.265 3.445 1.921 5.794 (.032)
D3S3657l 3.420 4.131 3.618 3.018 2.412 1.312 4.443 (.024)
D3S1238 1.571 3.556 3.382 2.904 2.335 1.231 4.012 (.056)
cessive mode of inheritance and onset of terminal renal
failure at age 122 years were identified (Meier and Hess
1965; Fillastre et al. 1976; Steele et al. 1980; Zollinger
et al. 1980; Grateau et al. 1986). However, all the re-
ported affected individuals suffer from retinitis pigmen-
tosa and most likely represent cases of late-onset Senior-
Løken syndrome. Some authors used the occurrence of
chronic renal failure at age 125 years as an exclusion
criterion for recessive nephronophthisis of the purely re-
nal form. Sporadic reports of adult patients were thought
to represent ADMCKD or other diagnoses (Kleinknecht
1989). In light of the identification of adolescent nephro-
nophthisis as a late-onset recessive form, classification
of these cases has to be reconsidered. The identification
of adolescent nephronophthisis as a novel disease entity
will therefore have implications for genetic counseling
in families with hereditary chronic renal failure. The ob-
servation of severe vascular changes consisting of thick-
ening of arteriolar and arterial walls that is due to medial
hypertrophy and concentric intimal fibrosis, with nar-
rowing of the arterial lumina, is usually not a common
feature of nephronophthisis. Whether vascular changes
are a specific feature of the disease process or result from
chronic renal failure cannot be determined, because no
morphological data on the early disease course are
available.
An important aspect in mapping of the disease gene
for adolescent nephronophthisis was the consanguine-
ous nature of the Venezuelan kindred, which allowed us
to follow a strategy of homozygosity mapping (Lander
and Botstein 1987). An assumption of identity by de-
scent was made on the basis of pedigree information,
cultural isolation, and the rarity of the disease in the
general population. On the basis of data of total-genome
haplotyping, a search for homozygous regions shared by
affected patients led to the identification of the respon-
sible gene locus, as indicated by a significant LOD score.
Further evidence of linkage was demonstrated by exten-
sive allele sharing among obligate and facultative car-
riers and affected individuals. The only exception was
affected individual D12, in whom no cosegregating
marker was identified. This individual carried the dis-
ease-associated haplotype only partially and in the het-
erozygous state. This finding might be explained by false
identity or phenocopy of individual D12. The concom-
itant occurrence of intermittent microscopic hematuria
and hearing deficit in individual D12 and in one of her
affected siblings might indicate the presence of a differ-
ent disease in these individuals. Since, in all LOD-score
calculations, individual D12 was classified as affected,
this discrepancy does not alter the highly significant
LOD scores calculated.
The critical region for adolescent nephronophthisis,
on 3q22, contains RYK, a gene encoding a receptor ty-
rosine kinase–related molecule with two leucine-rich
motifs in the extracellular domain (Stacker et al. 1993).
These elements appear to be implicated in highly specific
protein/protein interactions, as well as in cell-cell ad-
hesion (Rothberg et al. 1990). A similar function has
been proposed for nephrocystin, which is mutated in
NPH1, on the basis of its SH3 domain (Hildebrandt
1998). A potential role of RYK in kidney disease is also
suggested by its expression in isolated glomeruli, mes-
angial cells, and glomerular endothelial cells and during
rat kidney development (Takahashi et al. 1995; Kee et
al. 1997). Identification of the gene for adolescent ne-
phronophthisis might help to elucidate disease mecha-
nisms of tubulointerstitial fibrosis and renal cyst
development.
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